The prognosis in systemic lupus erythematosus (SLE) has improved due to better treatment
and care, but cardiovascular disease (CVD) still remains an important clinical problem, since …

Recent discoveries have further strengthened the critical role of SLE-related immune
dysregulation and metabolic disturbances in promoting accelerated CVD. Understanding …

Systemic Lupus Erythematosus (SLE) is associated with increased risk for accelerated
atherosclerosis and cardiovascular (CV) events including coronary heart disease …

Systemic lupus erythematosus (SLE) is associated with a significant risk of cardiovascular
disease (CVD), which substantially increases disease mortality and morbidity. The overall …

Secretory IgMs (SIgMs) were amongst the first identified immunoglobulins. However, their
importance was not fully understood and recent advances have shown they play a key role …

Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease including the
cardiovascular system. Atherosclerosis is the most common cardiovascular complication of …

Systemic lupus erythematosus (SLE) is a condition in which autoimmune inflammation
affects nearly every organ in the human body; it is characterized by a relapsing-remitting …

Atherosclerotic lesions create obvious vascular stenosis due to the presence of plaque, and
a large number of inflammatory macrophages are enriched in the thrombus. In this study, we …

Systemic lupus erythematosus (SLE) patients display an increased risk of cardiovascular
disease (CVD). With the improved clinical management of other classical severe …

Phosphorylcholine (ChoP) can be found in all life forms. Although this molecule was first
thought to be uncommon in bacteria, it is now appreciated that many bacteria express ChoP …